68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

计划入组 19 人 · 首次发布于 2015 年 9 月 24 日

[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)

计划入组 19 人 · 首次发布于 2018 年 10 月 30 日

The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer

计划入组 6 人 · 首次发布于 2026 年 1 月 23 日

Gastrin-17

corticotropin releasing factor receptor-2 agonists

Cholecystokinin-B/gastrin-receptor binding peptides (Philipps University)

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Alturas Minerals Corp

United States

Novartis Discontinues Phase 2 GRPR-Targeted Radioligand Lu-NeoB in Breast Cancer, Reaffirms Platform Commitment

Alpha-9 Oncology Secures $175M in Series C Funding to Advance Radiopharmaceutical Pipeline

Novel Radioligand Therapy [177Lu]Lu-NeoB Enters Clinical Testing for Advanced Breast Cancer